Bruush Oral Care Inc. - BRSH

BRSH Returns vs S&P 500 ⓘ

ticker	1 day return %	1 week return %	1 month return %	3 months return %	6 months return %	1 year return %	3 years return %	5 years return %	10 years return %	maximum return %
BRSH	12185.7	8500	0	45.8	-37.2	-97.5	-99.8	-99.8	-99.8	-99.8
S&P 500	-1.4	-1.8	0.9	5.8	10.5	30.3	25.3	88.0	187.4	33118.2

Compare BRSH with other assets →

Returns Charts ⓘ

Interactive Price Chart

Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline

Real-time Full Quote

Attribute	Value
symbol	BRSH
name	Bruush Oral Care Inc.
price	0.086
changes percentage	14.6667
change	0.011
day low	0.07
day high	0.095
year high	8.5
year low	0.043
market cap	8683506
price avg 50	0.09132
price avg 200	0.256835
exchange	NASDAQ
volume	27066546
avg volume	21348104
open	0.07
previous close	0.075
eps	-14.67
pe	-0.005862
earnings announcement	2023-03-10T18:00:00.000+0000
shares outstanding	100971000
timestamp	2024-06-27 20:00:01

Financial Statements ⓘ

We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.

Overall Annual Financial Health: 50.7%

Overall Quarterly Financial Health: 50.0%

Income Statements ⓘ

• Annual Income Statement

Note: The years below are fiscal years in accounting.

	2022	2021	Y/Y change %
0001913210
revenue	2632442	2620587	0.45
gross profit	1810059	1316263	37.51
gross profit ratio	0.69	0.5	36.90
research and development expenses	96431	0	NaN
operating expenses	12152984	6851047	77.39
interest income	1155288	80244	1339.72
interest expense	3843322	80244	4689.54
ebitda	-10493727	-5471442	-91.79
ebitdaratio	-3.99	-2.09	-90.93
operating income	-10509075	-5478773	-91.81
operating income ratio	-3.99	-2.09	-90.95
net income	-3178145	-5615027	43.40
net income ratio	-1.21	-2.14	43.65
eps	-16.55	-35.76	53.72

Overall Score of Annual Income Statement

0.62 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 3 million in 2022 from 3 million in 2021 representing a change of 0.45%. This indicates a sales growth, which is a positive sign for the company.

  Gross Profit: Gross Profit increased to 2 million in 2022 from 1 million in 2021 representing a change of 37.51%. This indicates a sales profitability growth, which is a positive sign for the company.

  Research and Development (R&D) Expenses: R&D Expenses increased to 0 million in 2022 from 0 million in 2021 representing a change of nan%. This shows that the company continues to invest in innovation and product development, which is crucial for long-term growth.

  Operating Expenses: Operating Expenses decreased to 12 million in 2022 from 7 million in 2021 representing a change of 77.39%. The decrease in operating expenses can be attributed to various factors such as improved profitability, cost optimization and financial stability, lower operating expenses can be positive indicators.

  Earnings per Share (EPS): EPS increased to -16.55 in 2022 from -16.55 in 2021 representing a change of 53.72%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.

• 📉 Negative Indicators

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) decreased to -10 million in 2022 from -5 million in 2021 representing a change of -91.79%. The decrease in EBITDA indicates declined operational efficiency and profitability.

  Operating Income: Operating income decreased to -11 million in 2022 from -5 million in 2021 representing a change of -91.81%. The decrease in operating income indicates worse operational performance and decreased profitability.

  Net Income: Net income decreased to -3 million in 2022 from -6 million in 2021 representing a change of 43.4%. The decrease in net income shows worsen profitability and indicates that the company is generating less profit for each dollar of revenue.

• Quarterly Income Statement

Note: The years below are fiscal years in accounting.

	2023Q4	2023Q3	Q/Q change %
0001913210
revenue	0	0	NaN
gross profit	0	0	NaN
gross profit ratio	0	0	NaN
research and development expenses	0	0	NaN
operating expenses	0	0	NaN
interest income	0	0	NaN
interest expense	0	0	NaN
ebitda	0	0	NaN
ebitdaratio	0	0	NaN
operating income	0	0	NaN
operating income ratio	0	0	NaN
net income	0	0	NaN
net income ratio	0	0	NaN
eps	0	0	NaN

Overall Score of Quarterly Income Statement

0.5 out of 1

Detailed Analysis

Balance Sheets ⓘ

• Annual Balance Sheet

Note: The years below are fiscal years in accounting.

	2022	2021	Y/Y change %
0001913210
total assets	1191117	1050166	13.42
total liabilities	2593913	4993364	-48.05
total equity	-1402796	-3943198	64.42
cash and cash equivalents	72921	14530	401.87
short term investments	18506	7067	161.87
long term investments	0	0	NaN
total current assets	1185498	1031268	14.96
total non current assets	5619	18898	-70.27
total current liabilities	2593913	4993364	-48.05
total non current liabilities	915483	0	NaN
common stock	23845704	13276909	79.60
retained earnings	-26386314	-17621043	-49.74
total debt	0	27144	-100.00

Overall Score of Annual Balance Sheet

0.9 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 1 million in 2022 from 1 million in 2021 representing a change of 13.42%. Suggesting a growth in asset holdings.

  Total Liabilities: Total Liabilities decreased to 3 million in 2022 from 5 million in 2021 representing a change of -48.05%. This indicates a decrease in overall liabilities.

  Total Equity: Total Equity increased to -1 million in 2022 from -4 million in 2021 representing a change of 64.42%. This indicates an increase in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents increased to 0 million in 2022 from 0 million in 2021 representing a change of 401.87%. This indicates an increase in available liquid assets.

  Short Term Investments: Short Term Investments increased to 0 million in 2022 from 0 million in 2021 representing a change of 161.87%. This indicates an increase in short-term investment holdings.

  Total Current Assets: Total Current Assets increased to 1 million in 2022 from 1 million in 2021 representing a change of 14.96%. This indicates a better liquidity position.

  Total Current Liabilities: Total Current Liabilities decreased to 3 million in 2022 from 5 million in 2021 representing a change of -48.05%. This indicates a lower short-term debt burden.

  Common Stock: Common Stock increased to 24 in 2022 from 13 in 2021 representing a change of 79.6%. This indicates an increase in ownership interest.

  Total Debt: Total Debt decreased to 0 million in 2022 from 0 million in 2021 representing a change of -100.0%. This indicates a reduction in overall debt burden.

• 📉 Negative Indicators

  Retained Earnings: Retained Earnings decreased to -26 million in 2022 from -18 million in 2021 representing a change of -49.74%. This indicates an accumulated losses.

• Quarterly Balance Sheet

Note: The years below are fiscal years in accounting.

	2023Q4	2023Q3	Q/Q change %
0001913210
total assets	0	0	NaN
total liabilities	0	0	NaN
total equity	0	0	NaN
cash and cash equivalents	0	0	NaN
short term investments	0	0	NaN
long term investments	0	0	NaN
total current assets	0	0	NaN
total non current assets	0	0	NaN
total current liabilities	0	0	NaN
total non current liabilities	0	0	NaN
common stock	0	0	NaN
retained earnings	0	0	NaN
total debt	0	0	NaN

Overall Score of Quarterly Balance Sheet

0.5 out of 1

Detailed Analysis

Cashflow Statements ⓘ

• Annual Cashflow Statement

Note: The years below are fiscal years in accounting.

	2022	2021	Y/Y change %
0001913210
net change in cash	58391	512.0	11304.58
operating cash flow	-12590778	-894.89	-1406860.62
free cash flow	-12592820	-903.16	-1394206.66
capital expenditure	-2042	-8.27	-24597.63
depreciation and amortization	15348	7.33	209257.52
deferred income tax	0	-569568	100.00
stock based compensation	279622	139.91	199755.62
accounts payables	-2020773	0	NaN
inventory	589037	536.17	109759.50
acquisitions net	0	0	NaN
investments in property plant and equipment	-2042	-8.27	-24597.63
net cash used for investing activites	-2042	-28.27	-7123.72
debt repayment	0	0	NaN
common stock issued	13672531	0	NaN
common stock repurchased	0	0	NaN
dividends paid	0	0	NaN
net cash used provided by financing activities	12651211	19.0	66571206.04
cash at end of period	72921	692.65	10427.87
accounts receivables	-14209	-106.52	-13239.65
cash at beginning of period	14530	180.65	7943.13

Overall Score of Annual Cashflow Statement

None

Detailed Analysis

• Quarterly Cashflow Statement

Note: The years below are fiscal years in accounting.

	2023Q4	2023Q3	Q/Q change %
0001913210
operating cash flow	0	0	NaN
free cash flow	0	0	NaN
capital expenditure	0	0	NaN
depreciation and amortization	0	0	NaN
deferred income tax	0	0	NaN
stock based compensation	0	0	NaN
accounts receivables	0	0	NaN
accounts payables	0	0	NaN
inventory	0	0	NaN
acquisitions net	0	0	NaN
investments in property plant and equipment	0	0	NaN
net cash used for investing activites	0	0	NaN
debt repayment	0	0	NaN
common stock issued	0	0	NaN
common stock repurchased	0	0	NaN
dividends paid	0	0	NaN
net cash used provided by financing activities	0	0	NaN
net change in cash	0	0	NaN
cash at end of period	0	194321	-100.0
cash at beginning of period	0	194321	-100.0

Overall Score of Quarterly Cashflow Statement

0.5 out of 1

Detailed Analysis

Earnings Transcripts ⓘ

No earnings transcripts available.

Earnings Per Share (EPS) ⓘ

Analyst Stock Recommendations ⓘ

Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.

Financial Ratios ⓘ

• Annual Financial Ratios

	2022-10-31	2021-10-31	Y/Y change %
FY
calendar year	2022	2021	NaN
revenue per share	13.71	16.69	-17.88
net income per share	-16.55	-35.76	53.73
operating cash flow per share	-65.56	-0.01	-1150155.77
free cash flow per share	-65.57	-0.01	-1139810.57
cash per share	0.48	0.14	246.09
book value per share	-7.3	-25.12	70.92
tangible book value per share	-7.3	-25.19	71.00
shareholders equity per share	-7.3	-25.12	70.92
interest debt per share	20.01	0.68	2825.93
market cap	5233035.5	8438750	-37.99
enterprise value	5160114.5	8451364	-38.94
pe ratio	-1.65	-1.5	-9.56
price to sales ratio	1.99	3.22	-38.27
pocfratio	-0.42	-9429.91	100.00
pfcf ratio	-0.42	-9343.58	100.00
pb ratio	-3.73	-2.14	-74.31
ptb ratio	-3.73	-2.14	-74.31
ev to sales	1.96	3.22	-39.22
enterprise value over ebitda	-0.49	-1.54	68.17
ev to operating cash flow	-0.41	-9444.0	100.00
ev to free cash flow	-0.41	-9357.55	100.00
earnings yield	-0.61	-0.67	8.73
free cash flow yield	-2.41	-0.0	-2248347.44
debt to equity	0	-0.01	100.00
debt to assets	0	0.03	-100.00
net debt to ebitda	0.01	-0.0	401.42
current ratio	0.46	0.21	121.29
interest coverage	-2.73	-68.28	96.00
income quality	1.44	0.16	801.30
dividend yield	0	0	NaN
payout ratio	0	0	NaN
sales general and administrative to revenue	1.76	0.61	187.78
research and ddevelopement to revenue	0.04	0	NaN
intangibles to total assets	0	0.01	-100.00
capex to operating cash flow	-0.0	-0.01	98.24
capex to revenue	0.0	0.0	24486.41
capex to depreciation	0.13	1.13	-88.20
stock based compensation to revenue	0.11	0.0	198855.59
graham number	52.15	142.16	-63.31
roic	2.72	1.4	94.15
return on tangible assets	-2.67	-5.41	50.64
graham net net	-11.72	-28.85	59.38
working capital	-1408415	-3962096	64.45
tangible asset value	-1402796	-3954664	64.53
net current asset value	-1408415	-3962096	64.45
invested capital	-1402796	-3943198	64.42
average receivables	105995	58946.5	79.82
average payables	1604307.5	1267991.5	26.52
average inventory	535859.5	1003312.5	-46.59
days sales outstanding	24.3	5.12	374.95
days payables outstanding	403.64	643.4	-37.26
days of inventory on hand	107.11	232.37	-53.90
receivables turnover	15.02	71.34	-78.94
payables turnover	0.9	0.57	59.40
inventory turnover	3.41	1.57	116.94
roe	2.27	1.42	59.10
capex per share	0.01	0.0	20091.46

• Positive

  ROE: Return on Equity (ROE) increased to 2.27 on 2022-10-31 from 1.42 on 2021-10-31, representing a change of 59.10%. Suggesting the company has been generating high returns for its shareholders.

• Negative

  PE Ratio: Price-to-Earnings (P/E) Ratio decreased to -1.65 on 2022-10-31 from -1.50 on 2021-10-31, representing a change of -9.56%. Indicating a decrease in the relative valuation of the company's stock.

  Current Ratio: Current Ratio increased to 0.46 on 2022-10-31 from 0.21 on 2021-10-31, representing a change of 121.29%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. However, it's below 1, indicating potential liquidity issues.

• Neutral

  Debt-to-Equity Ratio: Debt-to-Equity Ratio increased to 0.00 on 2022-10-31 from -0.01 on 2021-10-31, representing a change of 100.00%. The debt-to-equity ratio has been increasing, indicating that the company has been relying more on debt financing. Higher leverage may increase financial risk. However, a ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

• Quarterly Financial Ratios

	2023-10-31 Q4	2023-07-31 Q3	Q/Q change %
BRSH
calendar year	2023	2023	NaN
revenue per share	0	0	NaN
net income per share	0	0	NaN
operating cash flow per share	0	0	NaN
free cash flow per share	0	0	NaN
cash per share	0	0	NaN
book value per share	0	0	NaN
tangible book value per share	0	0	NaN
shareholders equity per share	0	0	NaN
interest debt per share	0	0	NaN
market cap	0	0	NaN
enterprise value	0	0	NaN
pe ratio	0	0	NaN
price to sales ratio	0	0	NaN
pocfratio	0	0	NaN
pfcf ratio	0	0	NaN
pb ratio	0	0	NaN
ptb ratio	0	0	NaN
ev to sales	0	0	NaN
enterprise value over ebitda	0	0	NaN
ev to operating cash flow	0	0	NaN
ev to free cash flow	0	0	NaN
earnings yield	None	None	NaN
free cash flow yield	0	0	NaN
debt to equity	0	0	NaN
debt to assets	0	0	NaN
net debt to ebitda	0	0	NaN
current ratio	0	0	NaN
interest coverage	0	0	NaN
income quality	0	0	NaN
dividend yield	None	None	NaN
payout ratio	0	0	NaN
sales general and administrative to revenue	0	0	NaN
research and ddevelopement to revenue	0	0	NaN
intangibles to total assets	0	0	NaN
capex to operating cash flow	0	0	NaN
capex to revenue	0	0	NaN
capex to depreciation	0	0	NaN
stock based compensation to revenue	0	0	NaN
graham number	0	0	NaN
roic	0	0	NaN
return on tangible assets	0	0	NaN
graham net net	0	0	NaN
working capital	0	0	NaN
tangible asset value	0	0	NaN
net current asset value	0	0	NaN
invested capital	0	0	NaN
average receivables	0	76302	-100.0
average payables	0	830642	-100.0
average inventory	0	71475	-100.0
days sales outstanding	0	0	NaN
days payables outstanding	0	0	NaN
days of inventory on hand	0	0	NaN
receivables turnover	0	0	NaN
payables turnover	0	0	NaN
inventory turnover	0	0	NaN
roe	0	0	NaN
capex per share	0	0	NaN

Growth Rates ⓘ

• Annual Growth

• Quarterly Growth

Intrinsic Value (Discounted Cash Flow) ⓘ

None